Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a study. Doctors have been cautious about prescribing these medications in patients with a history of pancreatitis due to the potential risk of worsening the condition, said Mahmoud Nassar, M.D., Ph.D. Acute pancreatitis is a sudden inflammation of the pancreas. The researchers used data from a database called TriNetX, which contains information from about 127 million patients across 15 countries, mainly from the United States. They identified 638,501...